Standartų projektų sąrašas

prEN 13586 Archyvuotas

Komentavimo iki data 2025-06-12

Kranai. Prieigos

This document specifies design requirements for non-powered access installed on cranes. NOTE 1 For other type of access, a requirement for information to be supplied is specified. Slidable, retractable means of access are excluded from the scope, except movable hoop guards. This document covers means of access to control stations and all access required for maintenance, certain erection and dismantling operations. For those cranes which are intended to be erected and dismantled frequently to change their places of work, specific requirements for the access needed during these operations are not covered by this document and can be given in the appropriate European Standards for specific crane types. Lighting of means of access is not covered by this document and can be given in the appropriate European Standards for specific crane types. NOTE 2 Specific requirements for access on particular types of cranes are given in the appropriate European Standard for the particular crane type. The requirements given in this document do not take into account the safety distances related to: - guarding against hazard from moving parts; - relative movement between crane and adjacent structure or the ground/floor; - hazardous surface temperature; - electrical equipment. The significant hazards covered by this document are identified in Annex A. This document is not applicable to cranes manufactured before the date of its publication.

Peržiūrėti metaduomenis

prEN 18000-3 Viešoji apklausa

Komentavimo iki data 2025-06-20

Gyvūnų sveikatos diagnostinė analizė. In vitro diagnostikos reagentų tikrinimas. 3 dalis. PGR tyrimų reagentai

This document specifies the control and approval of in vitro diagnostic reagents used in animal health for the detection, and/or absolute quantification of pathogen-specific nucleic acid (DNA or RNA) by PCR (e.g. endpoint PCR, real-time PCR, reverse transcription-PCR). This document is applicable to diagnostic reagents as a priority for infectious diseases (due to bacteria, viruses, fungi, or parasites, including genetic markers associated with pathogenicity, such as antimicrobial resistance or toxin production) and associated animal species for which harmonization of practices in this area is needed, i.e. those for which the national, regional or international regulatory framework provides for the control of trade in animals and/or animal products and/or the definition of a health status (absence of infection) of areas, establishments or individuals. Anyhow, all reagents designated by the competent authorities fall under the scope of this document. Nevertheless, the authorities or any other animal health stakeholder can choose to derogate in specific and very limited situations such as emerging, exotic or rare diseases. This document is not applicable to all existing diagnostic reagents, in particular those for which certain parameters described in this document cannot be validly evaluated in accordance with international requirements, due, e.g. to the absence of a specific reference standard and/or accessible and duly validated reference materials. The PCR diagnosis usually involves the use of a nucleic acid extraction and/or purification reagent, and a PCR reagent. The PCR method (when applicable) involves the successive use of these distinct reagents. PCR reagent control can be performed if the applicant provides evidence of the validity of the PCR reagent for use in the animal health diagnostic analysis, by proving its diagnostic performances with nucleic acid extracts obtained from the different matrices described in the instruction for use. The control of a complete PCR method by the applicant and the control organization is performed only if the PCR reagent cannot be dissociated from an nucleic acid extraction and/or purification systems. This document does not cover the control of the nucleic acid extraction and/or purification reagents, only. This document does not cover the step in which the user verifies a reagent (analysis method adoption). NOTE Prion diseases are not included in the scope of this third part of the EN 18000 series. Unlike other infectious diseases, prion diseases are not diagnosed using PCR assays because prions lack a nucleic acid component and consist solely of an abnormally folded conformer of the normal host protein.

Skaityti, komentuoti projektą Peržiūrėti metaduomenis

prEN IEC 62683-1:2025 Archyvuotas

Komentavimo iki data 2025-06-11

Žemosios įtampos perjungimo ir valdymo įrenginiai. Gaminio duomenys ir savybės, skirti informacijos mainams. 1 dalis. Katalogo duomenys

Peržiūrėti metaduomenis

EN 60315-4:1998/prA1 Archyvuotas

Komentavimo iki data 2025-06-11

Įvairių spinduliavimo klasių radijo imtuvų matavimo metodai. 4 dalis. Moduliuotojo dažnio radijo laidų imtuvai

Peržiūrėti metaduomenis

prEN 302 217-2 V3.4.0 (2025-04) Naujas

Komentavimo iki data 2025-06-15

Fiksuotojo radijo ryšio sistemos. Charakteristikos ir reikalavimai, keliami tiesioginio ryšio įrangai ir antenoms. 2 dalis. Skaitmeninės sistemos, veikiančios nuo 1 GHz iki 174,8 GHz dažnių juostose. Prieigos prie radijo ryšio spektro darnusis standartas

Skaityti, komentuoti projektą Peržiūrėti metaduomenis

prEN ISO 22359 Naujas

Komentavimo iki data 2025-06-15

Saugumas ir atsparumas. Papildomai apsaugotoms slėptuvėms skirtos gairės (ISO 22359:2024)

Identical scope from ISO 22359:2024

Skaityti, komentuoti projektą Peržiūrėti metaduomenis

EN ISO 14245:2021/prA1 Naujas

Komentavimo iki data 2025-06-15

Dujų balionai. Suskystintų naftos dujų balionų čiaupų techniniai reikalavimai ir bandymai. Automatinis užsidarymas. 1 keitinys (ISO 14245:2021/DAM 1:2025)

Skaityti, komentuoti projektą Peržiūrėti metaduomenis

prEN 1568-2 Archyvuotas